BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Rizos CV, Elisaf MS. Antihypertensive drugs and glucose metabolism. World J Cardiol 2014; 6(7): 517-530 [PMID: 25068013 DOI: 10.4330/wjc.v6.i7.517] [Cited by in CrossRef: 43] [Cited by in F6Publishing: 36] [Article Influence: 6.1] [Reference Citation Analysis]
Number Citing Articles
1 Zhao Y, Wang Q, Zhao X, Meng H, Yu J. Effect of antihypertensive drugs on breast cancer risk in female hypertensive patients: Evidence from observational studies. Clin Exp Hypertens 2018;40:22-7. [PMID: 29115847 DOI: 10.1080/10641963.2017.1288736] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
2 Eckel RH, Henry RR, Yue P, Dhalla A, Wong P, Jochelson P, Belardinelli L, Skyler JS. Effect of Ranolazine Monotherapy on Glycemic Control in Subjects With Type 2 Diabetes. Diabetes Care 2015;38:1189-96. [PMID: 26049552 DOI: 10.2337/dc14-2629] [Cited by in Crossref: 29] [Cited by in F6Publishing: 26] [Article Influence: 4.8] [Reference Citation Analysis]
3 Hu H, Hori A, Nishiura C, Sasaki N, Okazaki H, Nakagawa T, Honda T, Yamamoto S, Tomita K, Miyamoto T, Nagahama S, Uehara A, Yamamoto M, Murakami T, Shimizu C, Shimizu M, Eguchi M, Kochi T, Imai T, Okino A, Kuwahara K, Kashino I, Akter S, Kurotani K, Nanri A, Kabe I, Mizoue T, Kunugita N, Dohi S; Japan Epidemiology Collaboration on Occupational Health Study Group. Hba1c, Blood Pressure, and Lipid Control in People with Diabetes: Japan Epidemiology Collaboration on Occupational Health Study. PLoS One 2016;11:e0159071. [PMID: 27437997 DOI: 10.1371/journal.pone.0159071] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 4.0] [Reference Citation Analysis]
4 Fehér G, Pusch G. [Role of antihypertensive drugs in the treatment of migraine]. Orv Hetil 2015;156:179-85. [PMID: 25618859 DOI: 10.1556/OH.2015.30056] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
5 Ozcaliskan Ilkay H, Sahin H, Tanriverdi F, Samur G. Association Between Magnesium Status, Dietary Magnesium Intake, and Metabolic Control in Patients with Type 2 Diabetes Mellitus. J Am Coll Nutr 2019;38:31-9. [PMID: 30160617 DOI: 10.1080/07315724.2018.1476194] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
6 Meme N, Amwayi S, Nganga Z, Buregyeya E. Prevalence of undiagnosed diabetes and pre-diabetes among hypertensive patients attending Kiambu district Hospital, Kenya: a cross-sectional study. Pan Afr Med J 2015;22:286. [PMID: 26966482 DOI: 10.11604/pamj.2015.22.286.7395] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 1.2] [Reference Citation Analysis]
7 Leslie WS, Ali E, Harris L, Messow CM, Brosnahan NT, Thom G, McCombie EL, Barnes AC, Sattar N, Taylor R, Lean MEJ. Antihypertensive medication needs and blood pressure control with weight loss in the Diabetes Remission Clinical Trial (DiRECT). Diabetologia 2021;64:1927-38. [PMID: 34056684 DOI: 10.1007/s00125-021-05471-x] [Reference Citation Analysis]
8 Ali MY, Zaib S, Jannat S, Khan I. Inhibition of Angiotensin-I Converting Enzyme by Ginsenosides: Structure-Activity Relationships and Inhibitory Mechanism. J Agric Food Chem 2021;69:6073-86. [PMID: 34014666 DOI: 10.1021/acs.jafc.1c01231] [Reference Citation Analysis]
9 Tinahones FJ, Gallwitz B, Nordaby M, Götz S, Maldonado-Lutomirsky M, Woerle HJ, Broedl UC. Linagliptin as add-on to empagliflozin and metformin in patients with type 2 diabetes: Two 24-week randomized, double-blind, double-dummy, parallel-group trials. Diabetes Obes Metab 2017;19:266-74. [PMID: 27762093 DOI: 10.1111/dom.12814] [Cited by in Crossref: 29] [Cited by in F6Publishing: 24] [Article Influence: 5.8] [Reference Citation Analysis]
10 Katsiki N, Rizzo M, Mikhailidis DP, Mantzoros CS. New-Onset Diabetes and Statins: Throw the Bath Water Out, But, Please, Keep the Baby! Metabolism 2015;64:471-5. [DOI: 10.1016/j.metabol.2014.11.001] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 3.2] [Reference Citation Analysis]
11 Yin T, Kuo SC, Chang YY, Chen YT, Wang KK. Verapamil Use Is Associated With Reduction of Newly Diagnosed Diabetes Mellitus. J Clin Endocrinol Metab 2017;102:2604-10. [PMID: 28368479 DOI: 10.1210/jc.2016-3778] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 4.3] [Reference Citation Analysis]
12 Moghaddam Tabrizi F, Rasmi Y, Hosseinzadeh E, Rezaei S, Balvardi M, Kouchari MR, Ebrahimi G. Diabetes is associated with higher mortality and severity in hospitalized patients with COVID-19. EXCLI J 2021;20:444-53. [PMID: 33746672 DOI: 10.17179/excli2021-3403] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
13 Welty FK, Alfaddagh A, Elajami TK. Targeting inflammation in metabolic syndrome. Transl Res. 2016;167:257-280. [PMID: 26207884 DOI: 10.1016/j.trsl.2015.06.017] [Cited by in Crossref: 120] [Cited by in F6Publishing: 109] [Article Influence: 20.0] [Reference Citation Analysis]
14 Yi D, Kang YH. Drug-Induced Diabetes Mellitus. J Korean Diabetes 2017;18:160. [DOI: 10.4093/jkd.2017.18.3.160] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
15 Tosur M, Viau-Colindres J, Astudillo M, Redondo MJ, Lyons SK. Medication-induced hyperglycemia: pediatric perspective. BMJ Open Diabetes Res Care 2020;8:e000801. [PMID: 31958298 DOI: 10.1136/bmjdrc-2019-000801] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
16 Litwin M, Feber J, Niemirska A, Michałkiewicz J. Primary hypertension is a disease of premature vascular aging associated with neuro-immuno-metabolic abnormalities. Pediatr Nephrol 2016;31:185-94. [PMID: 25724169 DOI: 10.1007/s00467-015-3065-y] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 2.8] [Reference Citation Analysis]
17 Tan X, Benedict C. Sleep characteristics and HbA1c in patients with type 2 diabetes on glucose-lowering medication. BMJ Open Diabetes Res Care 2020;8:e001702. [PMID: 32868313 DOI: 10.1136/bmjdrc-2020-001702] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
18 Shimada K, Miyauchi K, Daida H. Azelnidipine and glucose tolerance: possible indications and treatment selection for hypertensive patients with metabolic disorders. Expert Review of Cardiovascular Therapy 2014;13:23-31. [DOI: 10.1586/14779072.2015.986464] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
19 de Lucena DD, de Sá JR, Medina-Pestana JO, Rangel ÉB. Modifiable Variables Are Major Risk Factors for Posttransplant Diabetes Mellitus in a Time-Dependent Manner in Kidney Transplant: An Observational Cohort Study. J Diabetes Res 2020;2020:1938703. [PMID: 32258163 DOI: 10.1155/2020/1938703] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
20 Fergus IV, Connell KL, Ferdinand KC. A Comparison of Vasodilating and Non-vasodilating Beta-Blockers and Their Effects on Cardiometabolic Risk. Curr Cardiol Rep 2015;17. [DOI: 10.1007/s11886-015-0592-x] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
21 Yao J, Gong X, Shi X, Fan S, Chen J, Chen Q. The efficacy of angiotensin converting enzyme inhibitors versus angiotensin II receptor blockers on insulin resistance in hypertensive patients: A protocol for a systematic review and meta-analysis. Medicine (Baltimore) 2020;99:e20674. [PMID: 32541513 DOI: 10.1097/MD.0000000000020674] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
22 Fathallah N, Slim R, Larif S, Hmouda H, Ben Salem C. Drug-Induced Hyperglycaemia and Diabetes. Drug Saf. 2015;38:1153-1168. [PMID: 26370106 DOI: 10.1007/s40264-015-0339-z] [Cited by in Crossref: 65] [Cited by in F6Publishing: 51] [Article Influence: 13.0] [Reference Citation Analysis]
23 Al Batran R, Gopal K, Aburasayn H, Eshreif A, Almutairi M, Greenwell AA, Campbell SA, Saleme B, Court EA, Eaton F, Light PE, Sutendra G, Ussher JR. The antianginal ranolazine mitigates obesity-induced nonalcoholic fatty liver disease and increases hepatic pyruvate dehydrogenase activity. JCI Insight 2019;4:124643. [PMID: 30626749 DOI: 10.1172/jci.insight.124643] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
24 Morsy MA, Heeba GH, Mahmoud ME. Ameliorative effect of eprosartan on high-fat diet/streptozotocin-induced early diabetic nephropathy in rats. European Journal of Pharmacology 2015;750:90-7. [DOI: 10.1016/j.ejphar.2015.01.027] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 2.2] [Reference Citation Analysis]
25 Carvalho DS, de Almeida AA, Borges AF, Vannucci Campos D. Treatments for diabetes mellitus type II: New perspectives regarding the possible role of calcium and cAMP interaction. Eur J Pharmacol 2018;830:9-16. [PMID: 29679542 DOI: 10.1016/j.ejphar.2018.04.002] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
26 Gammone MA, Efthymakis K, D'Orazio N. Effect of Third-Generation Beta Blockers on Weight Loss in a Population of Overweight-Obese Subjects in a Controlled Dietary Regimen. J Nutr Metab 2021;2021:5767306. [PMID: 34603773 DOI: 10.1155/2021/5767306] [Reference Citation Analysis]
27 Hassanabad MF, Fatehi M. Current Views on Dopaminergic Drugs Affecting Glucose Homeostasis. Curr Diabetes Rev 2019;15:93-9. [PMID: 29692257 DOI: 10.2174/1573399814666180424123912] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
28 Benedict A, Bansal N, Senina S, Hooper I, Lundberg L, de la Fuente C, Narayanan A, Gutting B, Kehn-Hall K. Repurposing FDA-approved drugs as therapeutics to treat Rift Valley fever virus infection. Front Microbiol 2015;6:676. [PMID: 26217313 DOI: 10.3389/fmicb.2015.00676] [Cited by in Crossref: 21] [Cited by in F6Publishing: 23] [Article Influence: 3.5] [Reference Citation Analysis]
29 Dharmarajan TS, Dharmarajan L. Tolerability of Antihypertensive Medications in Older Adults. Drugs Aging 2015;32:773-96. [DOI: 10.1007/s40266-015-0296-3] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 2.8] [Reference Citation Analysis]
30 Taylor BJ, Matthews KA, Hasler BP, Roecklein KA, Kline CE, Buysse DJ, Kravitz HM, Tiani AG, Harlow SD, Hall MH. Bedtime Variability and Metabolic Health in Midlife Women: The SWAN Sleep Study. Sleep 2016;39:457-65. [PMID: 27091639 DOI: 10.5665/sleep.5464] [Cited by in Crossref: 44] [Cited by in F6Publishing: 39] [Article Influence: 8.8] [Reference Citation Analysis]
31 Chang SW, McDonough CW, Gong Y, Johnson TA, Tsunoda T, Gamazon ER, Perera MA, Takahashi A, Tanaka T, Kubo M, Pepine CJ, Johnson JA, Cooper-DeHoff RM. Genome-wide association study identifies pharmacogenomic loci linked with specific antihypertensive drug treatment and new-onset diabetes. Pharmacogenomics J 2018;18:106-12. [PMID: 27670767 DOI: 10.1038/tpj.2016.67] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
32 Yang YS, Lim MH, Lee SO, Roh E, Ahn CH, Kwak SH, Cho YM, Kim S, Mari A, Park KS, Jung HS. Fimasartan increases glucose-stimulated insulin secretion in patients with type 2 diabetes and hypertension compared with amlodipine. Diabetes Obes Metab 2018;20:1670-7. [PMID: 29546730 DOI: 10.1111/dom.13282] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
33 Enang OE, Omoronyia OE, Ayuk AE, Nwafor KN, Legogie AO. Diabetes knowledge among non-diabetic hypertensive patients in Calabar, Nigeria. Pan Afr Med J 2020;36:198. [PMID: 32952842 DOI: 10.11604/pamj.2020.36.198.20522] [Reference Citation Analysis]
34 Marketou M, Gupta Y, Jain S, Vardas P. Differential Metabolic Effects of Beta-Blockers: an Updated Systematic Review of Nebivolol. Curr Hypertens Rep 2017;19:22. [PMID: 28283926 DOI: 10.1007/s11906-017-0716-3] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 3.8] [Reference Citation Analysis]
35 Jiménez-Rodríguez D, Conesa-Garcerán M, Belmonte-García T. Evaluation of the effect of relaxation therapy in patients with arterial hypertension. Enferm Clin (Engl Ed) 2019;29:178-85. [PMID: 30100138 DOI: 10.1016/j.enfcli.2018.07.005] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
36 Musial DC, Miranda-ferreira R, Padin JF, Arranz-tagarro JA, Parra-vitela AJ, Jurkiewicz A, Garcia AG, Jurkiewicz NH. Function of AT1 and AT2 receptors in atrial contractions from spontaneous hypertensive and diabetic-induced streptozotocin rats. Clin Exp Pharmacol Physiol 2018;45:1274-85. [DOI: 10.1111/1440-1681.13019] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]